Nichols & Pratt Advisers LLP MA Has $4.94 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Nichols & Pratt Advisers LLP MA decreased its position in CVS Health Co. (NYSE:CVS - Free Report) by 27.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 109,939 shares of the pharmacy operator's stock after selling 41,026 shares during the period. Nichols & Pratt Advisers LLP MA's holdings in CVS Health were worth $4,935,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of CVS. Hotchkis & Wiley Capital Management LLC lifted its stake in CVS Health by 34.8% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock valued at $748,085,000 after acquiring an additional 3,071,613 shares in the last quarter. ARGA Investment Management LP raised its stake in shares of CVS Health by 7,567.7% during the 4th quarter. ARGA Investment Management LP now owns 2,402,901 shares of the pharmacy operator's stock worth $107,866,000 after purchasing an additional 2,371,563 shares in the last quarter. State Street Corp raised its stake in shares of CVS Health by 3.6% during the 3rd quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after purchasing an additional 1,989,066 shares in the last quarter. TOMS Capital Investment Management LP bought a new stake in shares of CVS Health during the 3rd quarter worth approximately $121,987,000. Finally, Mizuho Markets Americas LLC raised its stake in shares of CVS Health by 1,470.2% during the 3rd quarter. Mizuho Markets Americas LLC now owns 1,396,464 shares of the pharmacy operator's stock worth $87,810,000 after purchasing an additional 1,307,531 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CVS. Piper Sandler dropped their price objective on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. TD Cowen boosted their target price on CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a report on Monday, November 25th. Barclays boosted their target price on CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Finally, Wolfe Research boosted their target price on CVS Health from 67.00 to 70.00 and gave the stock an "overweight" rating in a report on Tuesday, February 11th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $69.83.

CVS Health Price Performance

Shares of NYSE:CVS traded down $0.90 during trading on Monday, reaching $64.82. 7,077,932 shares of the company traded hands, compared to its average volume of 12,413,927. The company's 50 day moving average is $54.74 and its two-hundred day moving average is $56.53. The firm has a market capitalization of $81.72 billion, a PE ratio of 17.71, a PEG ratio of 0.98 and a beta of 0.61. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, sell-side analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.10%. CVS Health's dividend payout ratio is currently 72.68%.

Insider Buying and Selling

In other news, Director Michael F. Mahoney bought 30,000 shares of the company's stock in a transaction on Tuesday, February 18th. The stock was purchased at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.24% of the stock is owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.